potassium chloride has been researched along with losartan in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benel, L; Lees, D; Travo, P | 1 |
| Cachofeiro, V; Lahera, V; Maeso, R; Muñoz-García, R; Navarro-Cid, J; Rodrigo, E; Ruilope, LM | 1 |
| Dhalla, NS; Saward, L; Shao, Q; Zahradka, P | 1 |
| Borges, AC; Paiva, TB; Prioste, RN; Shimuta, SI | 1 |
| Kähönen, M; Kalliovalkama, J; Karjala, K; Mäkynen, H; Pörsti, I; Tolvanen, JP; Wu, X | 1 |
| Bessard, G; Chavanon, O; Devillier, P; Sessa, C; Stanke-Labesque, F; Tripodi, F | 1 |
| Doris, PA; Kähönen, M; Kalliovalkama, J; Pekki, A; Pörsti, I; Tolvanen, JP; Voipio, J; Wu, X; Ylitalo, P | 1 |
| Bianciotti, L; Fernandez, B; Kadarian, C; Rodano, V; Rodriguez-Campos, M; Vatta, M | 1 |
| Brailoiu, E; De Zeeuw, D; Filipeanu, CM; Henning, RH; Kok, JW; Nelemans, SA | 1 |
| Ganado, P; Sanz, M; Tejerina, T | 1 |
| Alonso, MJ; Balfagón, G; Rossoni, LV; Salaices, M; Vassallo, DV; Xavier, FE | 1 |
| Padilha, AS; Rossoni, LV; Vassallo, DV; Xavier, FE | 1 |
| Hussain, T; Siddiqui, AH | 1 |
| Dhein, S; Hoyer, A; Kempfert, J; Mohr, FW; Pritzwald-Stegmann, P | 1 |
14 other study(ies) available for potassium chloride and losartan
| Article | Year |
|---|---|
An hypothesis for the interpretation of the contractile response of vascular smooth muscle at the cellular level.
Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Biphenyl Compounds; Cells, Cultured; Imidazoles; Isradipine; Losartan; Muscle Contraction; Muscle, Smooth, Vascular; Potassium Chloride; Rats; Serotonin; Tetrazoles | 1996 |
Factors involved in the effects of losartan on endothelial dysfunction induced by aging in SHR.
Topics: Acetylcholine; Aging; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Kidney; Losartan; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitrites; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents; Vasodilation | 1998 |
Ca2+ mobilization in adult rat cardiomyocytes by angiotensin type 1 and 2 receptors.
Topics: Adenosine Triphosphate; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cells, Cultured; Heart; Imidazoles; Kinetics; Losartan; Male; Myocardial Contraction; Myocardium; Potassium Chloride; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Time Factors | 1998 |
Different pathways for Ca2+ mobilization by angiotensin II and carbachol in the circular muscle of the guinea-pig ileum.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Calcium Channel Blockers; Carbachol; Electric Stimulation; Female; Guinea Pigs; Ileum; Imidazoles; In Vitro Techniques; Isradipine; Losartan; Male; Membrane Potentials; Muscarinic Agonists; Muscle Contraction; Muscle, Smooth; Nickel; Nifedipine; Potassium Chloride; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrodotoxin; Vasoconstrictor Agents; Verapamil | 1999 |
Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diclofenac; Enalapril; Endothelium; Enzyme Inhibitors; Heart Rate; Hypertension; In Vitro Techniques; Losartan; Male; Mesenteric Arteries; Muscle Contraction; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstrictor Agents; Vasodilation | 1999 |
Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelin-1; Humans; In Vitro Techniques; Indomethacin; Losartan; Muscle Contraction; Muscle, Smooth, Vascular; Nitroarginine; Norepinephrine; Potassium Chloride; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Saphenous Vein; Serotonin; Stomach | 1999 |
Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Digoxin; Dihydropyridines; Enalapril; Heart; Hypertension; Losartan; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Organ Size; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium-Potassium-Exchanging ATPase; Tunica Media | 2000 |
AT-1 receptor and phospholipase C are involved in angiotensin III modulation of hypothalamic noradrenergic transmission.
Topics: Angiotensin III; Angiotensin Receptor Antagonists; Animals; Enzyme Inhibitors; Hypothalamus; Imidazoles; In Vitro Techniques; Inositol Phosphates; Losartan; Male; Neurons; Norepinephrine; Potassium Chloride; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Synaptic Transmission; Type C Phospholipases; Tyrosine 3-Monooxygenase | 2000 |
Intracellular angiotensin II elicits Ca2+ increases in A7r5 vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Calcium; Cell Line; Cell Membrane Permeability; Dose-Response Relationship, Drug; Imidazoles; Inositol 1,4,5-Trisphosphate; Liposomes; Losartan; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Potassium Chloride; Pyridines | 2001 |
Two angiotensin AT1 receptor antagonists, irbesartan and losartan, effects in cholesterol-fed rabbits.
Topics: Acetylcholine; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Biphenyl Compounds; Cholesterol; Cholesterol, Dietary; Coronary Vessels; Dose-Response Relationship, Drug; Hypercholesterolemia; In Vitro Techniques; Irbesartan; Lipoproteins, HDL; Lipoproteins, LDL; Losartan; Male; Mesenteric Arteries; Nitroprusside; Norepinephrine; Potassium Chloride; Rabbits; Receptor, Angiotensin, Type 1; Serotonin; Tetrazoles; Time Factors; Vasodilator Agents | 2002 |
Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries.
Topics: Animals; Antihypertensive Agents; Blotting, Western; Cardiotonic Agents; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Losartan; Male; Mesenteric Arteries; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Ouabain; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha; Vascular Resistance; Vasoconstrictor Agents | 2004 |
Ouabain at nanomolar concentration promotes synthesis and release of angiotensin II from the endothelium of the tail vascular bed of spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Enalaprilat; Endothelium, Vascular; Glucose; Hexamethonium; Injections, Intravenous; Losartan; Male; Muscle, Smooth, Vascular; Ouabain; Perfusion; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium-Potassium-Exchanging ATPase; Tail; Time Factors; Tromethamine; Vasodilation | 2004 |
Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Body Weight; Endothelial Cells; Endothelin-1; Enzyme Inhibitors; In Vitro Techniques; Losartan; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitroprusside; Obesity; Potassium Chloride; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Acute hemodynamic effects of angiotensin- converting enzyme inhibition after prolonged cardiac arrest with Bretschneider's solution.
Topics: Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelin Receptor Antagonists; Glucose; Heart Arrest; Hemodynamics; Losartan; Male; Malondialdehyde; Mannitol; Myocardial Reperfusion Injury; Oxygen Consumption; Peptides, Cyclic; Potassium Chloride; Procaine; Rabbits | 2014 |